The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Arginine
1.2.3 Folic Acid
1.2.4 Vitamin B6 & B12
1.2.5 Thiamine
1.2.6 Vitamin D
1.2.7 Betaine
1.2.8 Carglumic Acid
1.2.9 Sapropterin Dihydrochloride
1.2.10 Others
1.3 Market by Application
1.3.1 Global Amino Acid Metabolism Disorder Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Phenylketonuria
1.3.3 Maple Syrup Urine Disease
1.3.4 Argininosuccinic Acidemia
1.3.5 Citrullinemia
1.3.6 Homocystinuria
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Amino Acid Metabolism Disorder Drug Market Perspective (2019-2030)
2.2 Amino Acid Metabolism Disorder Drug Growth Trends by Region
2.2.1 Global Amino Acid Metabolism Disorder Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Amino Acid Metabolism Disorder Drug Historic Market Size by Region (2019-2024)
2.2.3 Amino Acid Metabolism Disorder Drug Forecasted Market Size by Region (2025-2030)
2.3 Amino Acid Metabolism Disorder Drug Market Dynamics
2.3.1 Amino Acid Metabolism Disorder Drug Industry Trends
2.3.2 Amino Acid Metabolism Disorder Drug Market Drivers
2.3.3 Amino Acid Metabolism Disorder Drug Market Challenges
2.3.4 Amino Acid Metabolism Disorder Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Amino Acid Metabolism Disorder Drug Players by Revenue
3.1.1 Global Top Amino Acid Metabolism Disorder Drug Players by Revenue (2019-2024)
3.1.2 Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Players (2019-2024)
3.2 Global Amino Acid Metabolism Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Amino Acid Metabolism Disorder Drug Revenue
3.4 Global Amino Acid Metabolism Disorder Drug Market Concentration Ratio
3.4.1 Global Amino Acid Metabolism Disorder Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amino Acid Metabolism Disorder Drug Revenue in 2023
3.5 Amino Acid Metabolism Disorder Drug Key Players Head office and Area Served
3.6 Key Players Amino Acid Metabolism Disorder Drug Product Solution and Service
3.7 Date of Enter into Amino Acid Metabolism Disorder Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Amino Acid Metabolism Disorder Drug Breakdown Data by Type
4.1 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Type (2019-2024)
4.2 Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Type (2025-2030)
5 Amino Acid Metabolism Disorder Drug Breakdown Data by Application
5.1 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Application (2019-2024)
5.2 Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Amino Acid Metabolism Disorder Drug Market Size (2019-2030)
6.2 North America Amino Acid Metabolism Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024)
6.4 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Amino Acid Metabolism Disorder Drug Market Size (2019-2030)
7.2 Europe Amino Acid Metabolism Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024)
7.4 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size (2019-2030)
8.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Amino Acid Metabolism Disorder Drug Market Size (2019-2030)
9.2 Latin America Amino Acid Metabolism Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024)
9.4 Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size (2019-2030)
10.2 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Amino Acid Metabolism Disorder Drug Introduction
11.2.4 Pfizer Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 AMINO
11.3.1 AMINO Company Detail
11.3.2 AMINO Business Overview
11.3.3 AMINO Amino Acid Metabolism Disorder Drug Introduction
11.3.4 AMINO Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.3.5 AMINO Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Amino Acid Metabolism Disorder Drug Introduction
11.4.4 Merck Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Recordati
11.5.1 Recordati Company Detail
11.5.2 Recordati Business Overview
11.5.3 Recordati Amino Acid Metabolism Disorder Drug Introduction
11.5.4 Recordati Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.5.5 Recordati Recent Development
11.6 DSM
11.6.1 DSM Company Detail
11.6.2 DSM Business Overview
11.6.3 DSM Amino Acid Metabolism Disorder Drug Introduction
11.6.4 DSM Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.6.5 DSM Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Amino Acid Metabolism Disorder Drug Introduction
11.7.4 Sanofi Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Kyowa Hakko Kirin
11.8.1 Kyowa Hakko Kirin Company Detail
11.8.2 Kyowa Hakko Kirin Business Overview
11.8.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Introduction
11.8.4 Kyowa Hakko Kirin Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.8.5 Kyowa Hakko Kirin Recent Development
11.9 BioMarin
11.9.1 BioMarin Company Detail
11.9.2 BioMarin Business Overview
11.9.3 BioMarin Amino Acid Metabolism Disorder Drug Introduction
11.9.4 BioMarin Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.9.5 BioMarin Recent Development
11.10 Swedish Orphan Biovitrum
11.10.1 Swedish Orphan Biovitrum Company Detail
11.10.2 Swedish Orphan Biovitrum Business Overview
11.10.3 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Introduction
11.10.4 Swedish Orphan Biovitrum Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.10.5 Swedish Orphan Biovitrum Recent Development
11.11 Shine Star (Hubei) Biological Engineering
11.11.1 Shine Star (Hubei) Biological Engineering Company Detail
11.11.2 Shine Star (Hubei) Biological Engineering Business Overview
11.11.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Introduction
11.11.4 Shine Star (Hubei) Biological Engineering Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)
11.11.5 Shine Star (Hubei) Biological Engineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Arginine
Table 3. Key Players of Folic Acid
Table 4. Key Players of Vitamin B6 & B12
Table 5. Key Players of Thiamine
Table 6. Key Players of Vitamin D
Table 7. Key Players of Betaine
Table 8. Key Players of Carglumic Acid
Table 9. Key Players of Sapropterin Dihydrochloride
Table 10. Key Players of Others
Table 11. Global Amino Acid Metabolism Disorder Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Amino Acid Metabolism Disorder Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 13. Global Amino Acid Metabolism Disorder Drug Market Size by Region (2019-2024) & (US$ Million)
Table 14. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2019-2024)
Table 15. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 16. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2025-2030)
Table 17. Amino Acid Metabolism Disorder Drug Market Trends
Table 18. Amino Acid Metabolism Disorder Drug Market Drivers
Table 19. Amino Acid Metabolism Disorder Drug Market Challenges
Table 20. Amino Acid Metabolism Disorder Drug Market Restraints
Table 21. Global Amino Acid Metabolism Disorder Drug Revenue by Players (2019-2024) & (US$ Million)
Table 22. Global Amino Acid Metabolism Disorder Drug Market Share by Players (2019-2024)
Table 23. Global Top Amino Acid Metabolism Disorder Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2023)
Table 24. Ranking of Global Top Amino Acid Metabolism Disorder Drug Companies by Revenue (US$ Million) in 2023
Table 25. Global 5 Largest Players Market Share by Amino Acid Metabolism Disorder Drug Revenue (CR5 and HHI) & (2019-2024)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Amino Acid Metabolism Disorder Drug Product Solution and Service
Table 28. Date of Enter into Amino Acid Metabolism Disorder Drug Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Amino Acid Metabolism Disorder Drug Market Size by Type (2019-2024) & (US$ Million)
Table 31. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2019-2024)
Table 32. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 33. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2025-2030)
Table 34. Global Amino Acid Metabolism Disorder Drug Market Size by Application (2019-2024) & (US$ Million)
Table 35. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2019-2024)
Table 36. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 37. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2025-2030)
Table 38. North America Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024) & (US$ Million)
Table 40. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030) & (US$ Million)
Table 41. Europe Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024) & (US$ Million)
Table 43. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030) & (US$ Million)
Table 44. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 45. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2019-2024) & (US$ Million)
Table 46. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2025-2030) & (US$ Million)
Table 47. Latin America Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024) & (US$ Million)
Table 49. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030) & (US$ Million)
Table 50. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 51. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024) & (US$ Million)
Table 52. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030) & (US$ Million)
Table 53. GlaxoSmithKline Company Detail
Table 54. GlaxoSmithKline Business Overview
Table 55. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product
Table 56. GlaxoSmithKline Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 57. GlaxoSmithKline Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer Amino Acid Metabolism Disorder Drug Product
Table 61. Pfizer Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. AMINO Company Detail
Table 64. AMINO Business Overview
Table 65. AMINO Amino Acid Metabolism Disorder Drug Product
Table 66. AMINO Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 67. AMINO Recent Development
Table 68. Merck Company Detail
Table 69. Merck Business Overview
Table 70. Merck Amino Acid Metabolism Disorder Drug Product
Table 71. Merck Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 72. Merck Recent Development
Table 73. Recordati Company Detail
Table 74. Recordati Business Overview
Table 75. Recordati Amino Acid Metabolism Disorder Drug Product
Table 76. Recordati Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 77. Recordati Recent Development
Table 78. DSM Company Detail
Table 79. DSM Business Overview
Table 80. DSM Amino Acid Metabolism Disorder Drug Product
Table 81. DSM Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 82. DSM Recent Development
Table 83. Sanofi Company Detail
Table 84. Sanofi Business Overview
Table 85. Sanofi Amino Acid Metabolism Disorder Drug Product
Table 86. Sanofi Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Kyowa Hakko Kirin Company Detail
Table 89. Kyowa Hakko Kirin Business Overview
Table 90. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product
Table 91. Kyowa Hakko Kirin Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 92. Kyowa Hakko Kirin Recent Development
Table 93. BioMarin Company Detail
Table 94. BioMarin Business Overview
Table 95. BioMarin Amino Acid Metabolism Disorder Drug Product
Table 96. BioMarin Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 97. BioMarin Recent Development
Table 98. Swedish Orphan Biovitrum Company Detail
Table 99. Swedish Orphan Biovitrum Business Overview
Table 100. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product
Table 101. Swedish Orphan Biovitrum Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 102. Swedish Orphan Biovitrum Recent Development
Table 103. Shine Star (Hubei) Biological Engineering Company Detail
Table 104. Shine Star (Hubei) Biological Engineering Business Overview
Table 105. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product
Table 106. Shine Star (Hubei) Biological Engineering Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)
Table 107. Shine Star (Hubei) Biological Engineering Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amino Acid Metabolism Disorder Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Amino Acid Metabolism Disorder Drug Market Share by Type: 2023 VS 2030
Figure 3. Arginine Features
Figure 4. Folic Acid Features
Figure 5. Vitamin B6 & B12 Features
Figure 6. Thiamine Features
Figure 7. Vitamin D Features
Figure 8. Betaine Features
Figure 9. Carglumic Acid Features
Figure 10. Sapropterin Dihydrochloride Features
Figure 11. Others Features
Figure 12. Global Amino Acid Metabolism Disorder Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 13. Global Amino Acid Metabolism Disorder Drug Market Share by Application: 2023 VS 2030
Figure 14. Phenylketonuria Case Studies
Figure 15. Maple Syrup Urine Disease Case Studies
Figure 16. Argininosuccinic Acidemia Case Studies
Figure 17. Citrullinemia Case Studies
Figure 18. Homocystinuria Case Studies
Figure 19. Amino Acid Metabolism Disorder Drug Report Years Considered
Figure 20. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 21. Global Amino Acid Metabolism Disorder Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 22. Global Amino Acid Metabolism Disorder Drug Market Share by Region: 2023 VS 2030
Figure 23. Global Amino Acid Metabolism Disorder Drug Market Share by Players in 2023
Figure 24. Global Top Amino Acid Metabolism Disorder Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2023)
Figure 25. The Top 10 and 5 Players Market Share by Amino Acid Metabolism Disorder Drug Revenue in 2023
Figure 26. North America Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. North America Amino Acid Metabolism Disorder Drug Market Share by Country (2019-2030)
Figure 28. United States Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Canada Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Amino Acid Metabolism Disorder Drug Market Share by Country (2019-2030)
Figure 32. Germany Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. France Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. U.K. Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Italy Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Russia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Nordic Countries Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Region (2019-2030)
Figure 40. China Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Japan Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Latin America Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Latin America Amino Acid Metabolism Disorder Drug Market Share by Country (2019-2030)
Figure 48. Mexico Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Brazil Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Country (2019-2030)
Figure 52. Turkey Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 56. AMINO Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 57. Merck Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 58. Recordati Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 59. DSM Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 60. Sanofi Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 61. Kyowa Hakko Kirin Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 62. BioMarin Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 63. Swedish Orphan Biovitrum Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 64. Shine Star (Hubei) Biological Engineering Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed